Bill 142: Reproductive Healthcare Act

This bill primarily affects pharmacies, family medicine clinics, gynecology practices, and other healthcare providers across Nova Scotia who prescribe, dispense, or administer contraceptives and hormone replacement therapy. Day-to-day billing practices will change, as providers will be required to submit claims directly to MSI rather than collecting payment or co-payments from patients. Pharmaceutical retailers and dispensing pharmacists will need to update their point-of-sale and insurance billing processes to reflect zero patient cost-sharing on covered reproductive health products. The administrative burden applies to solo practitioners and larger clinical operations alike, though larger pharmacies and multi-provider clinics may have more internal resources to adapt their billing systems quickly.